Crenolanib FDA Approval Status
FDA Approved: No
Generic name: crenolanib
Company: Arog Pharmaceuticals, Inc.
Treatment for: Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor
Crenolanib is benzimidazole type I kinase inhibitor in development for the treatment for multiple cancers, including acute myeloid leukemia (AML) and gastrointestinal stromal tumors (GIST).
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
